| Anthem Biosciences Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
|
|
|
|
|
|
|
|
| Mar'2025 | Mar'2024 | Mar'2023 | Mar'2022 | Mar'2021 | |
|---|---|---|---|---|---|
| SOURCES OF FUNDS : | |||||
| Equity Share Capital | 111.82 | 111.82 | 114.10 | 8.78 | 8.48 |
| Reserves | 2,361.40 | 1,821.26 | 1,627.52 | 1,346.69 | 692.99 |
| Equity Share Warrants | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity Application Money | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Shareholders Funds | 2,473.22 | 1,933.08 | 1,741.62 | 1,355.47 | 701.47 |
| Secured Loans | 108.95 | 166.59 | 105.19 | 35.49 | 100.01 |
| Unsecured Loans | 4.36 | 5.99 | 9.83 | 0.00 | 0.00 |
| Total Debt | 113.31 | 172.58 | 115.02 | 35.49 | 100.01 |
| Other Liabilities | 21.29 | 18.87 | 12.97 | 34.76 | 27.66 |
| Total Liabilities | 2,607.82 | 2,124.53 | 1,869.61 | 1,425.72 | 829.14 |
| APPLICATION OF FUNDS : | |||||
| Gross Block | 1,208.39 | 991.15 | 883.91 | 706.59 | 682.37 |
| Less: Accumulated Depreciation | 584.34 | 513.47 | 435.02 | 377.58 | 320.96 |
| Less:Impairment of Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Block | 624.05 | 477.68 | 448.89 | 329.01 | 361.41 |
| Lease Adjustments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Capital Work in Progress | 57.95 | 155.91 | 143.41 | 152.68 | 18.59 |
| Investments | 533.22 | 471.77 | 499.18 | 272.98 | 209.27 |
| Current Assets, Loans & Advances | |||||
| Inventories | 338.60 | 211.31 | 129.42 | 58.23 | 35.06 |
| Sundry Debtors | 447.91 | 489.83 | 274.07 | 326.19 | 254.65 |
| Cash and Bank Balance | 310.95 | 183.85 | 342.79 | 348.87 | 40.62 |
| Loans and Advances | 150.46 | 101.43 | 80.47 | 90.81 | 76.20 |
| Total Current Assets | 1,247.93 | 986.42 | 826.75 | 824.10 | 406.53 |
| Less : Current Liabilities and Provisions | |||||
| Current Liabilities | 200.89 | 189.94 | 113.98 | 174.07 | 178.89 |
| Provisions | 26.84 | 9.76 | 9.44 | 19.39 | 25.70 |
| Total CL & Provisions | 227.74 | 199.71 | 123.42 | 193.46 | 204.59 |
| Net Current Assets | 1,020.19 | 786.71 | 703.34 | 630.64 | 201.94 |
| Miscellaneous Expenses not written off | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax Assets | 41.41 | 41.41 | 24.91 | 15.94 | 13.87 |
| Deferred Tax Liability | 23.08 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Deferred Tax | 18.33 | 41.41 | 24.91 | 15.94 | 13.87 |
| Other Assets | 354.08 | 191.03 | 49.88 | 24.47 | 24.07 |
| Total Assets | 2,607.82 | 2,124.52 | 1,869.61 | 1,425.72 | 829.14 |
| Contingent Liabilities | 58.52 | 250.15 | 226.38 | 0.00 | 0.00 |